Patent classifications
A61K36/904
Pharmaceutical composition having preventative or treatment effect on inflammatory bowel diseases comprising stemonae radix extract
The present invention relates to a pharmaceutical composition, which comprises a Stemonae Radix extract, for preventing or treating the occurrence of inflammatory bowel diseases due to cigarette smoke, a method for preventing or treating the occurrence of inflammatory bowel diseases using the composition, a method for suppressing the expression of inflammatory cytokines using the composition, and to a food composition, which comprises the Stemonae Radix extract, for preventing or treating the occurrence of inflammatory bowel diseases due to cigarette smoke. The pharmaceutical composition comprising the Stemonae Radix extract, according to the present invention, reduces the level of MMP12 expression that is known to destroy IL-1, TNF-, and IL-6, which are inflammatory cytokines that accompany the inflammatory bowel diseases, and elastin and collagen, and can suppress decrease in the number of lactobacilli in the intestine, and thus can be widely used in developing a safe and effective inflammatory bowel diseases treating agent.
COMBINED EXTERNAL MEDICINE FOR TREATING PROSTATE DISEASES
The invention provides a combined external medicine for treating prostate diseases and a method using the same. The combined external medicine includes a pre-immune composition comprising multi-immune powder and a noble bottle tree decoction, a lesion active composition comprising the multi-immune powder and a first medical decoction prepared from a first Chinese medical composition for treating prostate diseases, and a double rib active composition comprising the multi-immune powder and a second medical decoction prepared from a second Chinese medical composition for conditioning liver and kidney. The method includes applying the pre-immune composition on skin of lesion part and skin of the left and right ribs; waiting for 5-10 minutes; applying the lesion active composition and the double rib active composition on the skin of the lesion part and skin of the left and right ribs; and airing for 10-40 minutes.
COMBINED EXTERNAL MEDICINE FOR TREATING PROSTATE DISEASES
The invention provides a combined external medicine for treating prostate diseases and a method using the same. The combined external medicine includes a pre-immune composition comprising multi-immune powder and a noble bottle tree decoction, a lesion active composition comprising the multi-immune powder and a first medical decoction prepared from a first Chinese medical composition for treating prostate diseases, and a double rib active composition comprising the multi-immune powder and a second medical decoction prepared from a second Chinese medical composition for conditioning liver and kidney. The method includes applying the pre-immune composition on skin of lesion part and skin of the left and right ribs; waiting for 5-10 minutes; applying the lesion active composition and the double rib active composition on the skin of the lesion part and skin of the left and right ribs; and airing for 10-40 minutes.
TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING URTICARIA, ECZEMA, AND ALLERGIC CONSTITUTION
Provided is a traditional Chinese medicine composition for treating urticaria, eczema, and allergic constitution. The composition is traditional Chinese medicine formula I, II, or an adjusted combination formula thereof. The traditional Chinese medicine formula I includes: Scutellariae Radix, Coptidis Rhizoma, Forsythiae fructus, Perillae folium, Magnoliae officinalis cortex, Atractylodis macrocephalae rhizoma, Radix Angelicae, Paeoniae alba radix, Cassiae semen, Cortex Phellodendri, Stemonae radix, Artemisiae annuae herba, Anemarrhenae rhizoma, Trichosanthis radix, Glycyrrhizae radix et rhizoma, Herba Menthae, Rhizoma Dryopteris Crassirhizomae, Salviae miltiorrhizae radix et rhizoma, Violae herba, and extract of Isatidis folium. The traditional Chinese medicine formula II includes Glycyrrhizae radix et rhizoma, Herba Menthae, Chuanxiong rhizoma, Gentianae radix et rhizoma, Moslae herba, Taraxaci herba, Rhei radix et rhizoma, Senecionis scandentis herba, Zingiberis rhizoma recens, Flos Lonicerae, Chebulae fructus, Belamcandae rhizoma, Pulsatillae radix, Moutan cortex, Magnoliae flos, Corni fructus, Herba Agastachis, Picrorhizae rhizoma, Dictamni cortex, Schizonepetae herba, and Flos Dendranthema morifolium (extract).
TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING URTICARIA, ECZEMA, AND ALLERGIC CONSTITUTION
Provided is a traditional Chinese medicine composition for treating urticaria, eczema, and allergic constitution. The composition is traditional Chinese medicine formula I, II, or an adjusted combination formula thereof. The traditional Chinese medicine formula I includes: Scutellariae Radix, Coptidis Rhizoma, Forsythiae fructus, Perillae folium, Magnoliae officinalis cortex, Atractylodis macrocephalae rhizoma, Radix Angelicae, Paeoniae alba radix, Cassiae semen, Cortex Phellodendri, Stemonae radix, Artemisiae annuae herba, Anemarrhenae rhizoma, Trichosanthis radix, Glycyrrhizae radix et rhizoma, Herba Menthae, Rhizoma Dryopteris Crassirhizomae, Salviae miltiorrhizae radix et rhizoma, Violae herba, and extract of Isatidis folium. The traditional Chinese medicine formula II includes Glycyrrhizae radix et rhizoma, Herba Menthae, Chuanxiong rhizoma, Gentianae radix et rhizoma, Moslae herba, Taraxaci herba, Rhei radix et rhizoma, Senecionis scandentis herba, Zingiberis rhizoma recens, Flos Lonicerae, Chebulae fructus, Belamcandae rhizoma, Pulsatillae radix, Moutan cortex, Magnoliae flos, Corni fructus, Herba Agastachis, Picrorhizae rhizoma, Dictamni cortex, Schizonepetae herba, and Flos Dendranthema morifolium (extract).
Medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, preparation method therefor and use method thereof
The present invention discloses a medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, a preparation method thereof and use methods thereof. The medicine comprises: lightyellow sophora root, glabrous greenbrier rhizome, bark of Chinese corktree, raw sessile stemona root, alumen, coptis root, cortex dictamni, chinaberry bark and root-bark, pangolin scales, amber, eucommia bark, tree peony bark, clematis root, common cnidium fruit, Chinese angelica, licorice root, common macrocarpium fruit, barbary wolfberry fruit, medicinal indianmulberry root, cherokee rose fruit, chinaroot greenbier rhizome, akebia fruit, milkvetch root, Japanese climbing fern spore, asiatic pennywort herb, mulberry leaf and frankincense. The present invention not only provides the medicine capable of effectively treating the acquired immunodeficiency syndrome, but also enables the medicine to be capable of being used in conjunction with other medical technical means to easily achieve a more ideal treatment effect.
Medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, preparation method therefor and use method thereof
The present invention discloses a medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, a preparation method thereof and use methods thereof. The medicine comprises: lightyellow sophora root, glabrous greenbrier rhizome, bark of Chinese corktree, raw sessile stemona root, alumen, coptis root, cortex dictamni, chinaberry bark and root-bark, pangolin scales, amber, eucommia bark, tree peony bark, clematis root, common cnidium fruit, Chinese angelica, licorice root, common macrocarpium fruit, barbary wolfberry fruit, medicinal indianmulberry root, cherokee rose fruit, chinaroot greenbier rhizome, akebia fruit, milkvetch root, Japanese climbing fern spore, asiatic pennywort herb, mulberry leaf and frankincense. The present invention not only provides the medicine capable of effectively treating the acquired immunodeficiency syndrome, but also enables the medicine to be capable of being used in conjunction with other medical technical means to easily achieve a more ideal treatment effect.
Pharmaceutical composition having preventative or treatment effect on inflammatory bowel diseases
The present invention relates to a pharmaceutical composition, which contains a mixture of extracts of Stemonae Radix, Asparagi Tuber, Scutellariae Radix, Schisandrae Fructus, Rehmanniae Radix Preparata, Armeniacae Semen, and Moutan Cortex Radicis, for suppressing the occurrence of inflammatory bowel diseases due to cigarette smoke, a method for preventing or treating inflammatory bowel diseases, a method for suppressing the expression of inflammatory cytokines by using the composition, and to a food composition, which contains a mixture of extracts of Stemonae Radix, Asparagi Tuber, Scutellariae Radix, Schisandrae Fructus, Rehmanniae Radix Preparata, Armeniacae Semen, and Moutan Cortex Radicis, for preventing or ameliorating inflammatory bowel diseases due to cigarette smoke. The pharmaceutical composition, according to the present invention, contains the mixture of extracts of Stemonae Radix, Asparagi Tuber, Scutellariae Radix, Schisandrae Fructus, Rehmanniae Radix Preparata, Armeniacae Semen, and Moutan Cortex Radicis, thereby reducing the level of MMP12 expression that is known to destroy IL-1, TNF-, IL-6 and MCP-1, which are inflammatory cytokines that accompany the inflammatory bowel diseases, elastin, and collagen, and thus can be widely used in developing a safe and effective inflammatory bowel disease treating agent.
Pharmaceutical composition having preventative or treatment effect on inflammatory bowel diseases
The present invention relates to a pharmaceutical composition, which contains a mixture of extracts of Stemonae Radix, Asparagi Tuber, Scutellariae Radix, Schisandrae Fructus, Rehmanniae Radix Preparata, Armeniacae Semen, and Moutan Cortex Radicis, for suppressing the occurrence of inflammatory bowel diseases due to cigarette smoke, a method for preventing or treating inflammatory bowel diseases, a method for suppressing the expression of inflammatory cytokines by using the composition, and to a food composition, which contains a mixture of extracts of Stemonae Radix, Asparagi Tuber, Scutellariae Radix, Schisandrae Fructus, Rehmanniae Radix Preparata, Armeniacae Semen, and Moutan Cortex Radicis, for preventing or ameliorating inflammatory bowel diseases due to cigarette smoke. The pharmaceutical composition, according to the present invention, contains the mixture of extracts of Stemonae Radix, Asparagi Tuber, Scutellariae Radix, Schisandrae Fructus, Rehmanniae Radix Preparata, Armeniacae Semen, and Moutan Cortex Radicis, thereby reducing the level of MMP12 expression that is known to destroy IL-1, TNF-, IL-6 and MCP-1, which are inflammatory cytokines that accompany the inflammatory bowel diseases, elastin, and collagen, and thus can be widely used in developing a safe and effective inflammatory bowel disease treating agent.
Pharmaceutical composition having preventative or treatment effect on inflammatory bowel diseases
The present invention relates to a pharmaceutical composition, which contains a mixture of extracts of Stemonae Radix, Asparagi Tuber, Scutellariae Radix, Schisandrae Fructus, Rehmanniae Radix Preparata, Armeniacae Semen, and Moutan Cortex Radicis, for suppressing the occurrence of inflammatory bowel diseases due to cigarette smoke, a method for preventing or treating inflammatory bowel diseases, a method for suppressing the expression of inflammatory cytokines by using the composition, and to a food composition, which contains a mixture of extracts of Stemonae Radix, Asparagi Tuber, Scutellariae Radix, Schisandrae Fructus, Rehmanniae Radix Preparata, Armeniacae Semen, and Moutan Cortex Radicis, for preventing or ameliorating inflammatory bowel diseases due to cigarette smoke. The pharmaceutical composition, according to the present invention, contains the mixture of extracts of Stemonae Radix, Asparagi Tuber, Scutellariae Radix, Schisandrae Fructus, Rehmanniae Radix Preparata, Armeniacae Semen, and Moutan Cortex Radicis, thereby reducing the level of MMP12 expression that is known to destroy IL-1, TNF-, IL-6 and MCP-1, which are inflammatory cytokines that accompany the inflammatory bowel diseases, elastin, and collagen, and thus can be widely used in developing a safe and effective inflammatory bowel disease treating agent.